Please provide your email address to receive an email when new articles are posted on . Immediate sequential bilateral cataract surgery with implantation of multifocal IOLs showed comparable outcomes ...

Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near tasks than those with monofocal ...

New types of intraocular lens, femtosecond laser, collagen cross-linking, and microinvasive glaucoma surgery (MIGS) will feature prominently at the upcoming American Society of Cataract and Refractive ...

Multifocal lenses use multiple refractive zones built in rings to give patients distance and near vision. These lenses are designed to address the problem of presbyopia, in which people over the age ...

January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...

When it comes to choosing an intraocular lens (IOL) to replace the eye's own natural lens, many cataract patients go with a multifocal option that allows them to see both far away and close-up. While ...

Same-day bilateral cataract surgery led to vision outcomes that were at least as good as those with delayed sequential procedures, with limited impact on most patients' daily activities, according to ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...